OKYO Pharma Limited

NasdaqCM OKYO

OKYO Pharma Limited Dividend Yield on December 30, 2024

OKYO Pharma Limited Dividend Yield is NA on December 30, 2024, a NA change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.

OKYO Pharma Limited 52-week high Dividend Yield is NA on December 30, 2024, which is NA below the current Dividend Yield.
OKYO Pharma Limited 52-week low Dividend Yield is NA on December 30, 2024, which is NA below the current Dividend Yield.
OKYO Pharma Limited average Dividend Yield for the last 52 weeks is NA.

Key data

Date	Dividend Yield	Free Cash Flow Yield	Earnings Yield	Enterprise Value (EV)

NasdaqCM: OKYO

OKYO Pharma Limited

CEO	Dr. Gary S. Jacob Ph.D.
IPO Date	May 17, 2022
Location	United Kingdom
Headquarters	55 Park Lane
Employees	8
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.

Key trends

Past 5 years